Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin α(v)β3, promotes endothelial cell survival, and induces angiogenesis in vivo

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 2958-2966

  Babic, Alexander M ^a   Chen, Chih Chiun ^a   Lau, Lester F ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; GROWTH FACTOR; INTEGRIN; LAMININ;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SURVIVAL; CONNECTIVE TISSUE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MALE; MITOGENESIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SECRETION; RAT; UMBILICAL VEIN; WOUND HEALING;

ANIMALIA; ULMUS;

EID: 0032913069     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.4.2958     Document Type: Article

References (60)

1. Babic, A., M. L. Kireeva, T. V. Kolesnikova, and L. F. Lau. 1998. CYR61, product of a growth factor-inducible immediate-early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95:6355-6360.
2. Bates, R. C., L. F. Lincz, and G. F. Burns. 1995. Involvement of integrins in cell survival. Cancer Metastasis Rev. 14:191-203.
3. Bischoff, J. 1997. Cell adhesion and angiogenesis. J. Clin. Invest. 99:373-376.
4. Bork, P. 1993. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327:125-130.
5. Bouck, N., V. Stellmach, and S. C. Hsu. 1996. How tumors become angiogenic. Adv. Cancer Res. 69:135-174.
6. Bradham, D. M., A. Igarashi, R. L. Potter, and G. R. Grotendorst. 1991. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114:1285-1294.
7. Brooks, P. C., A. M. P. Montgomery, M. Rosenfeld, R. Reisfel, T. Hu, G. Klier, and D. Cheresh. 1994. Integrin alpha V beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164.
8. Brunner, A., J. Chinn, M. Neubauer, and A. F. Purchio. 1991. Identification of a gene family regulated by transforming growth factor-beta. DNA Cell Biol. 10:293-300.
9. Bussolino, F., A. Mantovni, and G. Persico. 1997. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22:251-256.
10. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
11. 3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell Sci. 108:2655-2661.
12. Felding-Habermann, B., and D. A. Cheresh. 1993 Vitronectin and its receptors. Curr. Opin. Cell Biol. 5:864-868.
13. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med. 1:27-31.
14. Folkman, J. 1997. Blood vessel formation: what is its molecular basis. Cell 87:1153-1155.
15. Frazier, K., S. Williams, D. Kothapalli, H. Klapper, and G. R. Grotendorst. 1996. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 107:404-411.
16. Giancotti, F. G. 1997. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr. Opin. Cell Biol. 9:691-700.
17. Grotendorst, G. R. 1997. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev. 8:171-179.
18. Grotendorst, G. R., H. Okochi, and N. Hayashi. 1996. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7:469-480.
19. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
20. Hashimoto, Y., N. Shindo-Okada, M. Tani, Y. Nagamachi, K. Takeuchi, T. Shiroishi, H. Toma, and J. Yokota. 1998. expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses in vivo tumor growth and metastasis of K-1735 murine melanoma cells. J. Exp. Med. 187:289-296.
21. Igarashi, A., N. Hayashi, K. Nashiro, and K. Takehara. 1998. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocyte and vascular tumors. J. Cutaneous Pathol. 25:143-148.
22. Igarashi, A., K. Nashiro, K. Kikuchi, S. Sato, H. Ihn, M. Fujimoto, G. R. Grotendorst, and K. Takehara. 1996. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J. Invest. Dermatol. 106:729-733.
23. Igarashi, A., K. Nashiro, K. Kikuchi, S. Sato, H. Ihn, G. R. Grotendorst, and K. Tekehara. 1995. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol. 105:280-284.
24. Igarashi, A., H. Okochi, D. M. Bradham, and G. R. Grotendorst. 1993. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell 4:637-645.
25. Ito, Y., J. Aten, R. J. Bende, B. S. Oemar, T. J. Rabelink, J. J. Weening, and R. Goldschmeding. 1998. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 53:853-861.
26. Jackson, D., O. Volpert, N. Bouck, and D. I. H. Linzer. 1994. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266:1581-1584.
27. Jackson, M. R., E. W. Carney, S. J. Lye, and J. W. K. Ritchie. 1994. Localization of two angiogeneic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 15:341-353.
28. Jimenez, S. A., E. Hitraya, and J. Varga. 1996. Pathogenesis of scleroderma. Rheum. Dis. Clin. N. Am. 22:647-674.
29. Joliot, V., C. Martinerie, G. Dambrine, G. Plassiart, M. Brisac, J. Crochet, and B. Perbal. 1992. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol. Cell. Biol. 12:10-21.
30. 3. J. Biol. Chem. 273:3090-3096.
31. Kireeva, M. L., B. V. Latinkić, T. V. Kolesnikova, C.-C. Chen, G. P. Yang, A. S. Abler, and L. F. Lau. 1997. Cyr61 and Fisp12 are both signaling cell adhesion molecules: comparison of activities, metablism, and localization during development. Exp. Cell Res. 233:63-77.
32. Kireeva, M. L., F.-E. Mo, G. P. Yang, and L. F. Lau. 1996. Cyr61, product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol. Cell. Biol. 16:1326-1334.
33. Latinkić, B. V. 1994. Ph.D. thesis. The University of Illinois at Chicago, Chicago, Ill.
34. Maisonpierre, P. C., C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Comption, J. McClain, T. H. Aldrich, N. Papadopoulos, T. J. Daly, S. Davis, T. N. Sato, and G. D. Yancopoulos. 1997. Aniopoietin-2, a natural antagonist for Tis2 that disrupts in vivo angiogenesis. Science 277: 55-60.
35. Nakanishi, T., Y. Kimura, T. Tamura, H. Ichikawa, Y.-I. Yamaai, T. Sugimoto, and Y. M. Takigawa. 1997. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem. Biophys. Res. Commun. 234:206-210.
36. O'Brien, E. R., M. R. Garvin, R. Dev, D. K. Stewart, T. Hinohara, J. B. Simpson, and S. M. Schwartz. 1994. Angiogenesis in human coronary atherosclerotic plaques. Am. J. Pathol. 145:883-894.
37. O'Brien, T. P., and L. F. Lau. 1992. Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ. 3:645-654.
38. O'Brien, T. P., G. P. Yang, L. Sanders, and L. F. Lau. 1990. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10: 3569-3577.
39. Oemar, B. S., and T. F. Luscher. 1997. Connective tissue growth factor: friend or foe? Arterioscler. Thromb. Vasc. Biol. 17:1483-1489.
40. Oemar, B. S., A. Werner, J.-M. Garnier. D.-D. Do, N. Godoy, M. Nauck, W. Marz, J. Rupp, M. Pech, and T. F. Luscher. 1997. Human connective tissue growth factor is expressed in advanced atheroslerotic lesions. Circulation 95: 831-839.
41. Oliver, M. H., N. K. Harrison, J. E. Bishop, P. J. Cole, and G. J. Laurent. 1989. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci. 92:513-518.
42. Pennica, D., T. Swanson, J. W. Welsh, M. A. Roy, D. A. Lawrence, J. Lee, J. Brush, L. A. Taneyhill, B. Deuel, M. Lew, C. Watanabe, R. L. Cohen, M. F. Melhem, G. Finley, P. Quirke, A. D. Goddard, K. J. Hillan, A. L. Gurney, D. Botstein, and A. J. Levine. 1998. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-l-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95:14717-14722.
43. Polverini, P. J., N. P. Bouck, and F. Rastinjad. 1991. Assay and purification of naturally occurring inhibitor of angiogenesis. Methods Enzymol. 198:440-441.
44. Ribatti, D., F. P. Cantatore, A. Vacca, M. D'Amort, R. Ria, L. Roncali, and V. Pipitone. 1998. Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane. Clin. Rheumatol. 17:115-120.
45. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
46. Roberts, A. B., M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, J. H. Kehrl, and A. S. Fauci. 1986. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83:4167-4171.
47. Ruoslahti, E. 1996. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12:697-715.
48. Ryseck, R.-P., H. Macdonald-Bravo, M.-G. Mattei, and R. Bravo. 1991. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. 2:225-233.
49. Sastry, S. K., and A. F. Horwitz. 1996. Adhesion-growth factor interactions during differentiation: an integrated biological response. Dev. Biol. 180:455-467.
50. v-sri+. Mol. Cell. Biol. 16:481-486.
51. Schwartz, M. A., M. D. Schaller, and M. H. Ginsburg. 1995. Integrins: emergining paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11: 549-599.
52. Simmons, D. L., D. B. Levy, Y. Yannoni, and R. L. Erikson. 1989. Identification of a phorbol ester-repressible v-src-inducible gene. Proc. Natl. Acad. Sci. USA 86:1178-1182.
53. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenber, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Dammes, A. Walz, D. Marriott, S.-Y. Chan, S. Roczniak, and A. B. Shanafelt. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:27348-27357.
54. Stromblad, S., and D. A. Cheresh. 1996. Integrins, angiogenesis and vascular cell survival. Chem. Biol. 3:881-885.
55. Suri, C., P. F. Jones, S. Patan, S. Bartunkova, P. C. Maisonpierre, S. Davis, T. N. Sato, and G. D. Yancopoulos. 1996. Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
56. Varner, J. A. 1997. The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis, p. 361-390. In I. D. Goldberg and E. M. Rosen (ed.), Regulation of angiogenesis. Birkhauser Verlag, Basel, Switzerland.
57. Varner, J. A., and D. A. Cheresh. 1996. Integrins and cancer. Curr. Opin. Cell Biol. 8:724-730.
58. Wary, K. K., F. Mainiero, S. J. Isakoff, E. E. Marcantonio, and F. G. Giancotti. 1996. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87:733-743.
59. Wong, M., M. L. Kireeva, T. V. Kolesnikova, and L. F. Lau. 1997. Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev. Biol. 192:492-508.
60. Zhang, R., L. Averboukh, W. Zhu, H. Zhang, H. Jo, P. J. Dempsey, R. J. Coffey, A. B. Pardee, and P. Liang. 1998. Identification of rCop-1, a new member of CCN growth factor family, as a negative regulator or cell transformation. Mol. Cell. Biol. 18:6131-6141.